Clinical Trial Update: Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study evaluating the combination of veliparib and carboplatin in patients with HER2-negative metastatic breast cancer, with acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Veliparib (ABT-888) (veliparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Breast Carcinoma, Stage IIIB Breast Cancer AJCC v7 | Phase 1 | Status: ACTIVE_NOT_RECRUITING